# Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)

> **NCT00968409** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** PET
- **OTHER:** Laboratory Testing
- **OTHER:** Safety Testing
- **DRUG:** F18-FFNP

## Key facts

- **NCT ID:** NCT00968409
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968409, "Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00968409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*